Ticker
PROFCompany Name
PROFOUND MEDICAL CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 25.69M | 6.15 | $ 4.18M |
3/31/2025 | $ 33.65M | 8.77 | $ 3.84M |
12/31/2024 | $ 38.67M | 8.36 | $ 4.62M |
9/30/2024 | $ 19.65M | 4.06 | $ 4.84M |
6/30/2024 | $ 24.52M | 6.05 | $ 4.05M |
3/31/2024 | $ 30.06M | 4.01 | $ 7.49M |
12/31/2023 | $ 19.27M | 4.12 | $ 4.68M |
9/30/2023 | $ 24.54M | 6.48 | $ 3.79M |
6/30/2023 | $ 29.75M | 3.58 | $ 8.32M |
3/31/2023 | $ 31.61M | 9 | $ 3.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for PROFOUND MEDICAL CORP is calculated as follows: CashnEq [ $ 84.28M ] / LiabilitesC [ $ 3.36M ]
(=) Cash Ratio [ 25.07 ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |